News Search Results
Aug 27, 2025, 16:05 ET 10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Aug 25, 2025, 10:01 ET Single Cell Sequencing Market worth $3.46 billion by 2030 with 12.2% CAGR | MarketsandMarkets™
single cell sequencing market include 10x Genomics (US), Illumina Inc. (US), Thermo Fisher Scientific Inc. (US), BD (US), QIAGEN (Netherlands), and Danaher (US), among others. 10x Genomics (US): 10x Genomics is a leading company in the single cell
More news about: MarketsandMarkets
Aug 20, 2025, 17:46 ET Global Minimal Residual Disease Testing Market Gearing Up for Outstanding Expansion at a CAGR of ~11% by 2032 | DelveInsight
QIAGEN, Thermo Fisher Scientific, PerkinElmer Inc., MedGenome, BGI, Pacific Biosciences, GENEWIZ, Oxford Nanopore Technologies plc., Psomagen, Inc., 10x Genomics, Takara Bio Inc., Zymo Research Corporation., NuGEN Technologies, Inc. (Tecan Trading AG), Vela Diagnostics, CD Genomics., HTG Molecular Diagnostics,
More news about: DelveInsight Business Research, LLP
Aug 19, 2025, 09:00 ET 10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis
target and biomarker expression that RNA alone often fails to capture." Xenium Protein is now available globally. About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Aug 07, 2025, 16:05 ET 10x Genomics Reports Second Quarter 2025 Financial Results
regarding 10x Genomics, Inc.'s partnerships, plans, positioning, product launches, organization, goals, opportunities, potential, specifications, costs, enthusiasm, trends and adoption of 10x Genomics, Inc.'s products and services, expected performance advantages and benefits of using 10x Genomics, Inc.'s
More news about: 10x Genomics, Inc.
Aug 07, 2025, 16:04 ET 10x Genomics to Acquire Scale Biosciences
should not be relied upon as representing 10x Genomics, Inc.'s views as of any date subsequent to the date of this press release. 10x Genomics, Inc. disclaims any obligation to update any forward-looking statements provided to reflect any change in 10x Genomics' expectations or any change in events, conditions
More news about: 10x Genomics, Inc.
Jul 17, 2025, 09:00 ET 10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery
reach," said Serge Saxonov, CEO of 10x Genomics. "Spatial biology and advanced AI is the future of precision medicine. We are proud to partner with A*STAR GIS to accelerate the development of new diagnostics and therapies." About 10x Genomics10x Genomics is a life science technology
More news about: 10x Genomics, Inc.
Jul 10, 2025, 16:05 ET 10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025
https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 45 days after the event. About 10x Genomics 10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated
More news about: 10x Genomics, Inc.
Jun 30, 2025, 11:30 ET Metagenomics Market to Reach $7.78 Billion by 2032, Growing at a CAGR of 15.8% from 2025, Says Meticulous Research®
Takara Bio, Inc. (Japan), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), 10X GENOMICS, INC. (U.S.), Promega Corporation (U.S.), Cantata Bio, LLC, and Zymo Research Corporation (U.S.). Latest Industry Developments
More news about: Meticulous Market Research Pvt. Ltd.
Jun 25, 2025, 08:00 ET Avance Biosciences Launches NGS Center of Excellence in Houston
Element Biosciences, Oxford Nanopore, and PacBio for short- and long-read sequencing, alongside single-cell technologies such as 10x Genomics Chromium and Mission Bio's Tapestri. Supported by in-house bioinformatics and cross-functional scientific teams, the Center
More news about: Avance Biosciences, Inc.